Sales for CyPath Noninvasive Lung Cancer Diagnostic Increase 146% in First Quarter
Increased adoption of flow cytometry and artificial intelligence tools helps clinicians manage the rising number of indeterminate pulmonary nodules.
Latest Articles
Editor's Top Picks
Ordering Both ESR and CRP Tests Could Save Hospitals Nearly $10 Million Per Year, Study Finds
A peer-reviewed economic analysis challenges the assumption that erythrocyte sedimentation rate and C-reactive protein tests are interchangeable, finding that combined testing reduces misdiagnoses and lowers overall costs.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Molecular Test Detects Bile Duct Cancer at Twice the Rate of Standard Methods
The BiliSeq molecular test detected bile duct cancer in 82% of cases—compared to 44% with standard pathology—according to a six-year, multi-institutional study.
Equipment & Supply Spotlight
Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform
The integration gives more than 4,700 oncology providers across 1,600-plus community cancer care centers direct access to order and receive results from multiple precision oncology tests within a single clinical workflow.
News, Know-How & Standards
Disease Detection & Understanding
Sepsis Diagnostic Test Shapes ED Physician Decision-Making, Study Finds
A multicenter, vignette-based study found that adding a rapid sepsis test result to standard clinical data changed or reinforced diagnostic decisions in 86% of cases.
